It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Within the last decade, the science of molecular testing has evolved from single gene and single protein analysis to broad molecular profiling as a standard of care, quickly transitioning from research to practice. Terms such as genomics, transcriptomics, proteomics, circulating omics, and artificial intelligence are now commonplace, and this rapid evolution has left us with a significant knowledge gap within the medical community. In this paper, we attempt to bridge that gap and prepare the physician in oncology for multiomics, a group of technologies that have gone from looming on the horizon to become a clinical reality. The era of multiomics is here, and we must prepare ourselves for this exciting new age of cancer medicine.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
2 Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC, USA
3 National Cancer Center Hospital East, Chiba, Japan
4 Biognosys AG, Schlieren, Switzerland
5 Institute for Cancer Genetics and Informatics, Oslo University Hospital, Radiumhospitalet, Montebello, Oslo, Norway
6 Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy
7 JADBio Gnosis DA, N. Plastira 100, Science and Technology Park of Crete and Institute of Applied and Computational Mathematics, Foundation for Research and Technology Hellas, Heraklion, GR, Greece
8 Personalis, Inc., Menlo Park, CA, USA
9 Nuffield Division of Clinical and Laboratory Sciences, Level 4, Academic Block, John Radcliffe Infirmary, Headington, Oxford, UK
10 Clinica AMO, Rio Vermelho, Salvador-BA, Brasil
11 Yonsei Cancer Center, Yonsei University College of Medicine, Seodaemun-Ku, Seoul, Korea
12 Department of Medical Humanities in the School of Medicine, Creighton University, Omaha, NE, USA
13 Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
14 St. James’s Hospital/Trinity College Dublin, St. Raphael’s House, Dublin, Ireland
15 Cancer Institute, Fundacion Jimenez Diaz University Hospital, Autonomous University, Madrid, Spain
16 Indivumed GmbH, Hamburg, Germany